Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2008
11/12/2008CN101301360A Decoction for treating heavy metal poisoning constipation
11/12/2008CN101301356A Use of Schisandra chinensis extract in treating alcohol liver
11/12/2008CN101301355A Oil composition containing 1,8-cineole and flavanones extracted from Litsea lancilimba Merr. and Blumea Balsamifera DC. And use thereof
11/12/2008CN101301340A Oral Chinese medicine for treating colonitis induced hematochezia
11/12/2008CN101301337A Chinese medicine preparation for treating hepatic cirrhosis induced haematemesis
11/12/2008CN101301330A Codonopsis pilosula pollen capsules and preparation thereof
11/12/2008CN101301317A Compound abalone shell calcium tablet
11/12/2008CN101301301A Uses of rutin and quercetin-7-rhamnose in preparing anti-hepatitis medicament
11/12/2008CN101301290A Chemical combined medicament for treating lax
11/12/2008CN101301287A Use of composition of isoflavonoids from Belamcanda chinensis in preparing anti-hepatitis medicament
11/12/2008CN101301274A Compound mequindox soluble powder for animals and preparation thereof
11/12/2008CN101301110A Health cigarette
11/12/2008CN101301102A Heatstroke prevention functional drink
11/12/2008CN101301087A Method for extracting soluble calcium citrate using potato slag
11/12/2008CN101301081A Horseradish tree chawing tablet
11/12/2008CN101301015A Composite mulberry leaf tea
11/12/2008CN101301014A Cassia seed black tea and method for processing the cassia seed black tea
11/12/2008CN100432208C Health care medicinal liquor
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432065C Lactone monomer compound and its application in preparing anticancer medicine
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100431612C Hepatitis B nucleic acid vaccine, its preparation method and application
11/12/2008CN100431604C C1 inhibitor with short half-life for transient treatment
11/12/2008CN100431589C Fragrant pillow prepared from medicine for protecting and stengthening health
11/12/2008CN100431573C Medicine for treating aurigo
11/12/2008CN100431561C Preparing method and product of mile swertia herb dripping pill
11/12/2008CN100431553C Composition for improving obstacle under pharynx
11/12/2008CN100431552C Sea cucumber stomach strengthening composition and its preparing method
11/12/2008CN100431549C Nanometer dental caries prevention and antibiotic material, and its prepn. method and toothpaste containing the material
11/12/2008CN100431548C Chinese medicine composition for treating cold fever and liver damage and its preparing method
11/12/2008CN100431530C Soft polyene phosphatidylcholinecapsule and its prepn process
11/12/2008CN100431526C A rapidly disintegrating tablet of acid sensitive drug
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/11/2008US7449487 In particular of avocado, soya bean and/or lupin oils, for preparation of a medicament intended to stimulate expression of TGF-62 or expression of the plasminogen activator inhibitor PAI-1
11/11/2008US7449479 Hepatitis C virus inhibitors
11/11/2008US7449472 Methods of inhibiting p38 with substituted bicyclic pyrimidines
11/11/2008US7449446 Synergistic mixture; anticoagulants
11/06/2008WO2008134635A1 Heparin binding epidermal growth factor (hb-egf) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation
11/06/2008WO2008134300A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/06/2008WO2008134228A1 Benzoxazole compounds
11/06/2008WO2008133928A2 Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders
11/06/2008WO2008133709A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
11/06/2008WO2008133349A1 Agent for prevention of cirrhosis/precancerous lesion comprising natriuretic peptide as active ingredient
11/06/2008WO2008133225A1 Remedy for acute hepatitis or preventive/remedy for fulminant hepatitis
11/06/2008WO2008133128A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008133127A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008133098A1 Eradicating agent for helicobacter pylori
11/06/2008WO2008132846A1 Tricyclic heteroaryl compound
11/06/2008WO2008090480A3 Treatment of faecal incontinence
11/06/2008WO2008073933A3 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
11/06/2008WO2008068593A3 Motilide polymorphs
11/06/2008US20080275124 Powder of amino acids and method for producing the same
11/06/2008US20080275119 Treatment and Prevention of Liver Disease Associated with Parenteral Nutrition (PN)
11/06/2008US20080275114 Benzenesulfonamide derivatives; irritable bowel syndrome; may be co-administered with drug for inflammatory bowel disease; chemokine receptor inhibitors;
11/06/2008US20080275110 Increased oral absorption and/or transfer into blood circulation; foods, beverages; for lowering blood cholesterol levels
11/06/2008US20080275109 Drug, food or drink product containing proanthocyanidine derived from hop, hop bract or apple; prevents digestive diseases caused by Helicobacter pylori; freeze drying
11/06/2008US20080275102 And 3-oximidoindole derivatives; cannabinoid receptor antagonists; cardiovascular, gastrointestinal, autoimmune, and neurodegenerative disorders; obesity, infections; antidiabetic and antiallergen agents; acylation, oximination
11/06/2008US20080275098 Novel substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid
11/06/2008US20080275091 combination of an acid labile nonentric coated proton pump inhibitor such as omeprazole, tenatoprazole, substituted benzimidazole compounds that contain a sulfinyl group bridging substituted benzimidazole and pyridine, and a buffering agent such as NaHCO3, Al, Al/OH/3, CaCO3, night time heartburn
11/06/2008US20080275089 Compositions and methods to treat gastrointestinal disorders
11/06/2008US20080275085 Piperidine derivative and use thereof
11/06/2008US20080275069 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders
11/06/2008US20080275064 N-(2-Furan-2-yl-6-pyrazol-1-yl-pyrimidin-4-yl)-2-piperidin-1-yl-acetamide; antiischemic agents, antidiabetics; autoimmune diseases, Asthma, Obesity, Huntington's Disease, Dystonia, Dyskinesias, Parkinson's Disease, Inflammatory Bowl Disease
11/06/2008US20080275060 N-Hydroxyamide Derivatives and Use Thereof
11/06/2008US20080275052 Especially p38 MAP kinase alpha and beta; 2,4-difluorophenyl(3-(2-(trifluoromethyl)phenyl)-5,6-dihydroimidazo[1,5-a]pyrazin-7(8H)-yl)methanone
11/06/2008US20080275045 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine; 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-(4-morpholin-4-yl-phenyl)-amine; respiratory diseases, epilepsy, convulsions, seizures, gastrointestinal dysfunction, ischaemia, psychosis, schizophrenia, anxiety, depression, Alzheimer's disease
11/06/2008US20080275038 Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists
11/06/2008US20080275037 2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
11/06/2008US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/06/2008US20080275008 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
11/06/2008US20080274997 Fluid bed granulation process; water soluble grains; solid oral drug
11/06/2008US20080274985 Pharmaceutical composition useful for the treatment of peptic ulcer diseases
11/06/2008US20080274200 Dose titratable liquid dosage forms of acid labile drugs
11/06/2008US20080274174 Stable pancreatic enzyme compositions
11/06/2008US20080274123 Synaptic vesicle glycoprotein specific immunoglobulin for use in treatment and prevention of liver disorders; tissue targeted therapy
11/06/2008US20080274118 CD40 specific immunoglobulin for prevention and treatment of arthritic, cardiovascular, allergic, neurodegenerative and/or blood disorders
11/06/2008US20080274085 Nutrient broth comprising bifidobacterium for use as therapeutic in treatment of gastrointestinal disorders
11/06/2008US20080274084 Anti-Tnf Alpha Producing Lactic Acid Bacteria for the Treatment of Chronic Enterocolitis
11/06/2008US20080274065 basic amino acid, in free or salt form; monthly use; may comprise an abrasive system
11/06/2008US20080274064 Utilization of rhinologically active substances
11/06/2008DE102007023397A1 Neue pharmazeutische Zusammensetzung zur Verwendung als Laxativum Novel pharmaceutical composition for use as a laxative
11/06/2008CA2682519A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008CA2682400A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008CA2667621A1 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
11/05/2008EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity
11/05/2008EP1988100A1 Derivatives of glucagon-like peptide-2 and their therapeutic use
11/05/2008EP1988091A1 Tricyclic compounds
11/05/2008EP1988083A1 Triazole derivative
11/05/2008EP1988081A1 Binding inhibitor of sphingosine-1-phosphate
11/05/2008EP1988076A1 Amide derivative or salt thereof
11/05/2008EP1988075A1 Pyrrole derivative or salt thereof
11/05/2008EP1987023A1 Hydrate forms of amg706
11/05/2008EP1986952A2 Methods of treating cystic fibrosis
11/05/2008EP1986688A2 Methods of using antibodies against human il-22
11/05/2008EP1986669A1 Use of bifidobacterium longum for the prevention and treatment of inflammation
11/05/2008EP1986651A1 Use of a pyrimidinedione derivative for preventing or treating hepatitis c
11/05/2008EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
1 ... 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 ... 1258